Weight Management

Medically supervised weight care — built on your labs, not a promo code

A monthly program with a real medical evaluation, baseline lab work, FDA-approved medication when appropriate, and follow-ups with the same nurse practitioner — because sustainable weight care is a clinical relationship, not a subscription box.

A starting point

BMI calculator

BMI is one screening number — useful context, not a verdict. It can't see muscle mass, body composition, or your health story, which is why the evaluation exists.

Calculate your BMI

Your numbers stay on this page — nothing is saved or sent anywhere.

Standard BMI ranges: below 18.5 (underweight), 18.5–24.9, 25–29.9 (overweight), 30+ (obesity). FDA labeling for Wegovy® and Zepbound® generally involves a BMI of 30+, or 27+ with a weight-related health condition — but candidacy is always determined by your full evaluation, not this number alone.

How it works

Three phases, one provider

1

Evaluate

A 45-minute medical evaluation plus baseline labs — thyroid, blood sugar, lipids, and liver health — to find what's helping or hindering your weight before anything is prescribed.

2

Plan

A personalized plan across nutrition, movement, sleep, and habits — with an honest conversation about whether medication is clinically appropriate for you, and when it isn't.

3

Adjust

Monthly video check-ins with the same provider: reviewing progress, refreshing labs when due, adjusting treatment safely, and keeping the plan matched to your real life.

Our medication solutions

FDA-approved GLP-1 & GIP medications — injectable or oral.

When medication supports your goals, we prescribe from FDA-approved GLP-1 and GIP medications — injectable or oral — chosen after your evaluation, labs, and history. Same standard every time: real evidence, honest expectations, ongoing monitoring.

Wegovy® (semaglutide) injection

A once-weekly FDA-approved injectable medication for chronic weight management, used alongside nutrition and activity changes. Semaglutide works by acting on appetite regulation — most patients describe quieter "food noise" and earlier fullness.

Once-weekly self-injection with simple training at your visit
Gradual dose ramp-up to minimize side effects
Ongoing monitoring at monthly check-ins

Zepbound® (tirzepatide) injection

A once-weekly FDA-approved injectable that works on two appetite- and metabolism-related pathways (GIP and GLP-1). For appropriate patients, clinical trials have shown substantial average weight reduction alongside lifestyle changes.

Once-weekly self-injection with dose titration over time
Candidacy determined by evaluation, labs & history
Side effects and expectations reviewed before you start

Oral Wegovy® (Semaglutide 25mg pill)

FDA-approved December 2025 — the first oral GLP-1 pill approved specifically for weight management, not just diabetes. Trial data showed ~16.6% average weight loss, similar to the injectable version. Same class warnings apply (thyroid C-cell tumor risk).

Foundayo™ (orforglipron)

Eli Lilly's oral GLP-1, FDA-approved April 2026. Unlike other GLP-1 pills, it has no food or water timing restrictions — take it any time of day.

Rybelsus® (oral semaglutide)

The older, lower-dose oral semaglutide pill. Approved only for type 2 diabetes — using it for weight loss is off-label and notably less effective (~4% vs ~16.6% weight loss).

Eligibility, dosing, and suitability are clinical decisions made after your evaluation — FDA labeling for these medications generally involves BMI thresholds and weight-related health conditions, which your provider will review with you. Medication costs and insurance coverage vary and are discussed transparently before anything is prescribed. Weight loss results vary from person to person; we don't publish before-and-after photos — we'd rather earn your trust with good medicine.

FAQs

Common questions about the program

Start with the evaluation, not the prescription.

That order is the whole difference.

Book your evaluation